Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-25-031034

Chief Operating Officer acquired 79,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nabulsi Azmi Chief Operating Officer 2025-02-27 Grant or award +79,200 312,590 D
Derivatives
Nabulsi Azmi Chief Operating Officer 2025-02-27 Grant or award · Stock Option (Right to Buy) +55,000 55,000 D
Loading xslF345X05/ownership.xml…